Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- University of North Carolina, Chapel Hill
- Study ID
- NCT05480995
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- 18F-fluorofuranylnorprogesterone PET / MRI — DRUGSubjects will receive a PET/MRI with 18F-fluorofuranylnorprogesterone tracer
Study Details
Purpose: The aim of this study is to assess the sensitivity and specificity of FFNP PET/MRI for diagnosis of endometriosis. Participants: A total of 24 participants will be recruited from individuals with clinically suspected endometriosis. Procedures (methods): This is a prospective, one arm, single center study of 24 subjects with clinically suspected endometriosis to demonstrate FFNP PET-MRI's clinical utility for diagnosis of endometriosis.
Key Dates
- Start date
- Jan 17, 2023
- Status verified
- Jan 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: 18F-fluorofuranylnorprogesterone PET / MRIAll enrolled subjects will receive the tracer and then have a PET/MRI scan.
Primary Outcome Measure
Sensitivity of 18F-fluorofuranylnorprogesterone (FFNP) PET/MR for evaluating endometriosis [ Time Frame: Upon completion of all study image data collection for all participants [approximately 1 year] ]
Central Contacts
- Markeela Lipscomb, CCRC919-843-3670
- Hannah Mignosa-Martin984-215-4963
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | Jorge Oldan, MD (PRINCIPAL_INVESTIGATOR) Yueh Lee, MD, PhD (SUB_INVESTIGATOR) Steven Young, MD (SUB_INVESTIGATOR) Erin Carey, MD (SUB_INVESTIGATOR) Kristen Olinger, MD (SUB_INVESTIGATOR) Lauren Burke, MD (SUB_INVESTIGATOR) Lauren Schiff, MD (SUB_INVESTIGATOR) Robert Huynh, PharmD (SUB_INVESTIGATOR) |
Find similar trials in Chapel Hill, NC
By condition
By specialty
By research site
Related Studies
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPHASE3 · Recruiting · Sumitomo Pharma Switzerland GmbH · Mobile, Alabama
- Vaginal Ecosystem and Network in the United States StudyEnrolling By Invitation · Vaginal Biome Science · Fullerton, California
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruiting · Mayo Clinic · Scottsdale, Arizona